Revvity Price to Free Cash Flow Ratio 2010-2023 | RVTY
Revvity Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-05-01 | 102.60 | 1292.19 | |
2023-12-31 | 109.16 | $0.08 | 1374.82 |
2023-09-30 | 110.47 | $-0.46 | 0.00 |
2023-06-30 | 118.48 | $1.21 | 98.19 |
2023-03-31 | 132.84 | $3.01 | 44.10 |
2022-12-31 | 139.71 | $4.70 | 29.73 |
2022-09-30 | 119.82 | $6.35 | 18.86 |
2022-06-30 | 141.55 | $7.53 | 18.79 |
2022-03-31 | 173.57 | $9.30 | 18.67 |
2021-12-31 | 199.95 | $11.35 | 17.61 |
2021-09-30 | 172.27 | $13.11 | 13.14 |
2021-06-30 | 153.43 | $12.43 | 12.34 |
2021-03-31 | 127.41 | $8.93 | 14.26 |
2020-12-31 | 142.45 | $6.58 | 21.66 |
2020-09-30 | 124.52 | $3.11 | 40.01 |
2020-06-30 | 97.25 | $1.68 | 57.84 |
2019-12-31 | 96.12 | $2.58 | 37.26 |
2019-09-30 | 84.24 | $2.79 | 30.17 |
2019-06-30 | 95.22 | $2.34 | 40.62 |
2019-03-31 | 95.17 | $3.06 | 31.11 |
2018-12-31 | 77.51 | $3.78 | 20.48 |
2020-03-31 | 74.57 | $1.51 | 49.37 |
2018-09-30 | 95.91 | $2.17 | 44.15 |
2018-06-30 | 72.14 | $1.61 | 44.75 |
2018-03-31 | 74.53 | $1.49 | 49.96 |
2017-12-31 | 71.90 | $2.26 | 31.83 |
2017-09-30 | 67.76 | $2.71 | 24.98 |
2017-06-30 | 66.87 | $2.68 | 24.93 |
2017-03-31 | 56.91 | $3.29 | 17.32 |
2016-12-31 | 51.05 | $3.08 | 16.57 |
2016-09-30 | 54.85 | $2.63 | 20.88 |
2016-06-30 | 51.18 | $2.70 | 18.96 |
2016-03-31 | 48.23 | $2.22 | 21.72 |
2015-12-31 | 52.15 | $2.28 | 22.83 |
2015-09-30 | 44.68 | $2.10 | 21.30 |
2015-06-30 | 51.11 | $2.11 | 24.17 |
2015-03-31 | 49.58 | $2.01 | 24.67 |
2014-12-31 | 42.33 | $2.26 | 18.74 |
2014-09-30 | 42.13 | $1.99 | 21.12 |
2014-06-30 | 45.19 | $2.32 | 19.50 |
2014-03-31 | 43.40 | $1.10 | 39.45 |
2013-12-31 | 39.65 | $0.75 | 53.16 |
2013-09-30 | 36.23 | $0.25 | 145.93 |
2013-06-30 | 31.13 | $0.05 | 610.39 |
2012-12-31 | 30.28 | $0.96 | 31.68 |
2012-09-30 | 28.05 | $2.49 | 11.28 |
2012-06-30 | 24.49 | $2.41 | 10.15 |
2012-03-31 | 26.18 | $2.15 | 12.19 |
2011-12-31 | 18.87 | $2.45 | 7.72 |
2013-03-31 | 32.16 | $1.03 | 31.19 |
2011-09-30 | 18.06 | $1.19 | 15.12 |
2011-06-30 | 25.23 | $0.90 | 28.01 |
2011-03-31 | 24.57 | $1.15 | 21.38 |
2010-12-31 | 24.08 | $1.20 | 20.06 |
2010-09-30 | 21.52 | $1.49 | 14.40 |
2010-06-30 | 19.15 | $1.72 | 11.16 |
2010-03-31 | 22.08 | $1.33 | 16.63 |
2009-12-31 | 18.96 | $1.06 | 17.94 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.674B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $121.982B | 15.31 |
Cencora (COR) | United States | $45.721B | 17.82 |
ICON (ICLR) | Ireland | $24.881B | 23.49 |
DiDi Global (DIDIY) | China | $23.865B | 0.00 |
Avantor (AVTR) | United States | $16.588B | 24.42 |
Viatris (VTRS) | United States | $13.847B | 3.98 |
CochLear (CHEOY) | Australia | $13.505B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
Natera (NTRA) | United States | $11.509B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
Solventum (SOLV) | United States | $11.239B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
HealthEquity (HQY) | United States | $6.843B | 51.12 |
Organon (OGN) | United States | $4.843B | 4.66 |
Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
Doximity (DOCS) | United States | $4.479B | 33.35 |
PACS (PACS) | United States | $3.736B | 0.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
Progyny (PGNY) | United States | $3.103B | 52.08 |
GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
Life Times (LTH) | United States | $2.557B | 27.08 |
Premier (PINC) | United States | $2.523B | 9.24 |
AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
Agilon Health (AGL) | United States | $2.039B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
NovoCure (NVCR) | Jersey | $1.371B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
Enhabit (EHAB) | United States | $0.511B | 46.27 |
LifeMD (LFMD) | United States | $0.476B | 0.00 |
CareDx (CDNA) | United States | $0.475B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
MultiPlan (MPLN) | United States | $0.414B | 0.00 |
Beauty Health (SKIN) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.353B | 56.50 |
Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
ModivCare (MODV) | United States | $0.317B | 4.20 |
Sharecare (SHCR) | United States | $0.263B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
Biodesix (BDSX) | United States | $0.143B | 0.00 |
So-Young (SY) | China | $0.127B | 42.67 |
Oncology Institute (TOI) | United States | $0.083B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |